How Does Surfactant Prevent Alveolar Collapse?
Pulmonary surfactant prevents alveolar collapse during exhalation by dynamically lowering alveolar surface tension as alveolar surface area decreases. Without this specialized mixture of lipids and proteins, the physical tendency of water molecules lining the alveoli to minimize surface area would generate excessive collapsing pressure, causing atelectasis. By concentrating at the air-liquid interface when lung volume drops, surfactant stabilizes alveoli of varying sizes, equalizes transpulmonary pressures, reduces the muscular effort needed for subsequent inhalation, and ensures efficient pulmonary gas exchange.
The Physical Challenge of Alveolar Surface Tension
The interior surface of human alveoli is coated with a thin layer of aqueous fluid necessary for the diffusion of oxygen and carbon dioxide. Because water molecules exhibit strong cohesive forces via hydrogen bonding, the surface layer tends to contract to the smallest possible surface area. This contracting force is known as surface tension (\(\gamma\)).
In a spherical structure like an alveolus, surface tension generates an inward collapsing pressure (\(P\)). This relationship is governed by the Law of Laplace:
\[P = \frac{2\gamma}{r}\]
In this equation:
- \(P\) represents the collapsing or distending pressure required to keep the bubble open.
- \(\gamma\) represents the surface tension at the liquid-gas interface.
- \(r\) represents the radius of the alveolus.
According to Laplace's law, if surface tension were constant across all alveoli, smaller alveoli (smaller \(r\)) would generate substantially higher inward pressures than larger alveoli. Consequently, air would flow from smaller alveoli into larger ones, causing progressive microatelectasis in smaller air sacs and overexpansion in larger ones.
Composition of Pulmonary Surfactant
Pulmonary surfactant is synthesized, stored, and secreted by alveolar type II (ATII) epithelial cells. It consists of roughly 90% lipids and 10% proteins by weight:
- Dipalmitoylphosphatidylcholine (DPPC): The primary phospholipid component, accounting for roughly 40% to 50% of surfactant mass. DPPC contains two saturated palmitic acid chains, allowing tight intermolecular packing at the air-water interface.
- Other Phospholipids and Neutral Lipids: Phosphatidylglycerol (PG), unsaturated phosphatidylcholines, and cholesterol provide fluid properties essential for rapid spreading and adsorption.
- Surfactant Proteins (SP-A, SP-B, SP-C, and SP-D):
- SP-B and SP-C: Small hydrophobic proteins that facilitate the rapid insertion and organization of phospholipids into the surface monolayer. They also stabilize the lipid film during compression.
- SP-A and SP-D: Hydrophilic collectins primarily involved in innate immune defense and the structural organization of tubular myelin.
The Mechanism of Action During Exhalation
When the lungs deflate during exhalation, alveolar surface area contracts rapidly. The surfactant film undergoes specific biophysical changes that prevent alveolar collapse:
1. Interfacial Compression and Packing
At high lung volumes (end-inhalation), surfactant molecules are spread across an expanded surface area. As exhalation proceeds, the surface area shrinks. Because DPPC possesses two saturated, straight fatty acid tails, the lipid molecules pack tightly together without steric hindrance. Hydrophobic interactions between these tails exclude water molecules from the surface interface.
2. Selective Squeeze-Out of Fluid Lipids
As compression continues, less stable unsaturated lipids and neutral lipids are squeezed out of the interfacial monolayer into an underlying surfactant reservoir, a process facilitated by SP-B and SP-C. This leaves a monolayer predominantly enriched in DPPC, which can withstand high lateral compression without buckling.
3. Dynamic Reduction of Surface Tension
Because DPPC molecules directly oppose water-water intermolecular cohesion at the interface, surface tension drops precipitously. At the end of exhalation, surface tension falls from its baseline aqueous level of approximately \(70\text{ mN/m}\) down to near-zero values (less than \(2\text{ to }5\text{ mN/m}\)).
Plugging a near-zero \(\gamma\) into the Law of Laplace explains why collapse is averted:
\[\lim_{\gamma \to 0} P = \lim_{\gamma \to 0} \frac{2\gamma}{r} \approx 0\]
Despite a reduced radius (\(r\)) during exhalation, the drastic drop in surface tension (\(\gamma\)) offsets the decrease in radius, keeping the inward collapsing pressure minimal.
Stabilization Across Differing Alveolar Radii
Alveoli in the human lung do not have uniform diameters. Surfactant concentration changes proportionally with alveolar surface area:
- In smaller alveoli, surfactant molecules pack more densely, lowering surface tension to a greater extent.
- In larger alveoli, surfactant molecules are spaced farther apart, resulting in relatively higher surface tension.
This self-adjusting mechanism balances the ratio of \(\frac{\gamma}{r}\) across neighboring units:
\[\frac{\gamma_1}{r_1} \approx \frac{\gamma_2}{r_2}\]
Because collapsing pressures equalize across different alveolar dimensions, gas transfer between interconnected alveoli is halted, preventing smaller units from emptying their volume into larger ones.
Physiological Consequences of Surfactant Preservation
By maintaining alveolar patency at low lung volumes, surfactant secures several key pulmonary functions:
- Prevention of End-Expiratory Atelectasis: Alveoli remain open throughout the entire respiratory cycle, preserving functional residual capacity (FRC).
- Increased Pulmonary Compliance: Lowering surface tension reduces the work of breathing, decreasing the muscular force required to expand the lungs during subsequent inspiration.
- Reduction of Hydrostatic Edema: High surface tension exerts a negative suction pressure that pulls interstitial fluid into the alveolar airspace. By keeping surface tension minimal, surfactant keeps the alveoli dry for optimal gas diffusion.